GALXC

Serial Number 90531584
730

Registration Progress

Application Filed
Feb 17, 2021
Under Examination
Mar 12, 2024
Approved for Publication
Jan 16, 2024
Published for Opposition
Jan 16, 2024
Registered

Trademark Image

GALXC

Basic Information

Serial Number
90531584
Filing Date
February 17, 2021
Published for Opposition
January 16, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
730
Status Date
Sep 12, 2024
Application
Pending
Classes
005 040 042

Rights Holder

Dicerna Pharmaceuticals, Inc.

03
Address
75 Hayden Avenue
Lexington, MA 02421

Ownership History

Dicerna Pharmaceuticals, Inc.

Original Applicant
03
Lexington, MA

Dicerna Pharmaceuticals, Inc.

Owner at Publication
03
Lexington, MA

Legal Representation

Attorney
Bridget H. Labutta

USPTO Deadlines

All Deadlines Cleared

All 8 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

50 events
Date Code Type Description Documents
Sep 12, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 12, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 12, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 12, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 12, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 16, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 16, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 27, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 13, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 10, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 10, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 10, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 10, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Aug 10, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
May 11, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
May 11, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 11, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 6, 2023 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Feb 7, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 7, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 7, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 7, 2022 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
May 25, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 25, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 25, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 7, 2022 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Feb 2, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 2, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 2, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 13, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 13, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 13, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 5, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 5, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 5, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 5, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jan 5, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 31, 2021 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Aug 31, 2021 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Aug 31, 2021 CNSL R SUSPENSION LETTER WRITTEN Loading...
Aug 12, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 12, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 12, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 27, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 27, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 27, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 20, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
May 19, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 25, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 25, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...

Detailed Classifications

Class 005
Biologic preparations for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases and viral infections; drug delivery agents consisting of a biological compound in the form of a molecular complex that acts as a platform that facilitates delivery of ribonucleic acid RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies; oligonucleotide compounds for use in the targeted delivery of RNA interference (RNAi) therapy; oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents intravenously or subcutaneously for use in targeted pharmaceutical therapies for a wide range of medical purposes
Class 040
Custom manufacture of oligonucleotides
Class 042
Research and development of pharmaceutical products; research and development of oligonucleotide drug delivery platforms for use in the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections

Additional Information

Design Mark
The mark consists of the words "GALXC" in stylized font, with "XC" in enlarged capital letters. The letter "X" in "GALXC" is partially composed of a repeating pattern of light, medium and dark shaded triangles.
Pseudo Mark
GALAXY

Classification

International Classes
005 040 042